<unk>  is a anticonvulsant, gamma aminobutyric acid transaminase inhibitor that is FDA approved for the treatment of refractory complex partial seizures and infantile spams. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include weight increased, arthralgia, confusion, coordination problem, memory impairment, somnolence, tremor, blurred vision, diplopia, nystagmus, infection of ear, otitis media, aggressive behavior, dysmenorrhea, bronchitis, upper respiratory infection and fatigue.
Vigabatrin
Stiripentol
Tasimelteon
Metizoline
Fosaprepitant
Dirlotapide
Mafenide
Aglepristone